FDA to hold patient-focused meeting on Huntington's, Parkinson's

FDA will hold a public meeting Sept. 22 to discuss Huntington's and Parkinson's diseases. The meeting is part of FDA's Patient-Focused Drug Development initiative, in which the agency is holding 20 pu...